Harbour BioMed Company
Harbour BioMed (HKEX: 02142.HK) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and immunology.
Technology:
Others
Estimated Revenue:
$10M to $50M
Founded Date:
2016
Headquarters:
China
Funding Status:
Late Stage Venture
Employee Number:
51-100
Industry:
Loss of Proteostasis